El Instituto de Biología Molecular y Celular de Plantas (CSIC-UPV) mejora la tecnología para producir múltiples fragmentos cortos de ARN que pueden ‘apagar’ varios genes sin efectos secundarios...
Read more
It has been described an innovative technology that enables the large-scale analysis of antibodies in biological samples. Using microscopic beads marked with stable isotopes, this advance surpasses tr...
Read more
It has been identified 24 neopeptides that could be good targets for designing preventive cancer vaccines in people with Lynch syndrome. The results show that the selected peptides are repeated among ...
Read more
Recently, procedures have been established at the European level to facilitate the conduct of studies involving seasonal vaccines, enabling sponsors to initiate clinical trials in time to coincide wit...
Read more
In the RNA field, many companies are facing challenges when advancing research projects due to time, expertise, and resource constraints. Many biotechnology firms are seeking to overcome these hurdles...
Read more
The study shows that resistant strains persist despite conjugate vaccines and warns of worse outcomes in people with a poor prognosis treated with amoxicillin.
Read more
The Fight Infections Foundation and IrsiCaixa, in collaboration with the Germans Trias Hospital, have published a study indicating that the main cause of reinfections is viral evolution
Read more
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer cases could be prevented.
Read more
With 414 pages of updated content (ISBN: 978-3-11-142468-2), the book provides a comprehensive overview of nucleic acid modifications, backbone engineering, and therapeutic conjugates, as well as the ...
Read more
The new project will assess the real-world integration of the RTS,S malaria vaccine into routine immunisation in Sierra Leone
Read more
Abyntek distributes the products of Sino Biological, a leading biotechnology company that has raised the standard in recombinant protein production with its ProPure™ line, specifically designed for ...
Read more
Results showed that after a single dose, the vaccine reduced symptomatic dengue cases by around 50% with the first dose and by 62% with the second, and hospitalizations by 68%. Protection began 14 day...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
